First Time Loading...

Agios Pharmaceuticals Inc
NASDAQ:AGIO

Watchlist Manager
Agios Pharmaceuticals Inc Logo
Agios Pharmaceuticals Inc
NASDAQ:AGIO
Watchlist
Price: 34.48 USD -0.29% Market Closed
Updated: May 4, 2024

Wall Street
Price Targets

AGIO Price Targets Summary
Agios Pharmaceuticals Inc

Wall Street analysts forecast AGIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AGIO is 43.66 USD with a low forecast of 29.29 USD and a high forecast of 51.45 USD.

Lowest
Price Target
29.29 USD
15% Downside
Average
Price Target
43.66 USD
27% Upside
Highest
Price Target
51.45 USD
49% Upside

AGIO Last Price Targets
Agios Pharmaceuticals Inc

The latest public price target was made on Feb 3, 2023 by Unknown Analyst from Piper Sandler , who expects AGIO stock to rise by 19% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst Price Target Date Article
Unknown Analyst
Piper Sandler
41 USD
Upside 19%
1 year ago
Feb 3, 2023
Piper Sandler Initiates Coverage On Agios Pharmaceuticals with Overweight Rating, Announces Price Target of $41
Benzinga
Unknown Analyst
Piper Sandler
Price Target 41 USD
Upside/Downside 19%
View Source
Agios Pharmaceuticals Inc Competitors:
Price Targets
6855
Ascentage Pharma Group International
65% Upside
SRZN
Surrozen Inc
233% Upside
IMRX
Immuneering Corp
720% Upside
BNTX
BioNTech SE
30% Upside
INCY
Incyte Corp
43% Upside
KYMR
Kymera Therapeutics Inc
44% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
50% Upside
1875
TOT BIOPHARM International Co Ltd
110% Upside

Revenue
Forecast

Revenue Estimate
Agios Pharmaceuticals Inc

For the last 8 years the compound annual growth rate for Agios Pharmaceuticals Inc's revenue is -9%. The projected CAGR for the next 3 years is 96%.

-9%
Past Growth
96%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Agios Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Agios Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AGIO's stock price target?
Price Target
43.66 USD

According to Wall Street analysts, the average 1-year price target for AGIO is 43.66 USD with a low forecast of 29.29 USD and a high forecast of 51.45 USD.

What is Agios Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
96%

For the last 8 years the compound annual growth rate for Agios Pharmaceuticals Inc's revenue is -9%. The projected CAGR for the next 3 years is 96%.